209 related articles for article (PubMed ID: 18288089)
1. Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal.
Papaleo F; Ghozland S; Ingallinesi M; Roberts AJ; Koob GF; Contarino A
Neuropsychopharmacology; 2008 Nov; 33(12):2878-87. PubMed ID: 18288089
[TBL] [Abstract][Full Text] [Related]
2. Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal.
Papaleo F; Kitchener P; Contarino A
Neuron; 2007 Feb; 53(4):577-89. PubMed ID: 17296558
[TBL] [Abstract][Full Text] [Related]
3. CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.
Navarro-Zaragoza J; Núñez C; Ruiz-Medina J; Laorden ML; Valverde O; Milanés MV
Br J Pharmacol; 2011 Feb; 162(4):851-62. PubMed ID: 20973778
[TBL] [Abstract][Full Text] [Related]
4. CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping.
Ingallinesi M; Rouibi K; Le Moine C; Papaleo F; Contarino A
Mol Psychiatry; 2012 Dec; 17(12):1283-94. PubMed ID: 21946917
[TBL] [Abstract][Full Text] [Related]
5. Sex differences between CRF1 receptor deficient mice following naloxone-precipitated morphine withdrawal in a conditioned place aversion paradigm: implication of HPA axis.
García-Carmona JA; Baroja-Mazo A; Milanés MV; Laorden ML
PLoS One; 2015; 10(4):e0121125. PubMed ID: 25830629
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing factor (CRF) receptor-1 is involved in cardiac noradrenergic activity observed during naloxone-precipitated morphine withdrawal.
Martínez-Laorden E; García-Carmona JA; Baroja-Mazo A; Romecín P; Atucha NM; Milanés MV; Laorden ML
Br J Pharmacol; 2014 Feb; 171(3):688-700. PubMed ID: 24490859
[TBL] [Abstract][Full Text] [Related]
7. The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal.
Contarino A; Papaleo F
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18649-54. PubMed ID: 16339307
[TBL] [Abstract][Full Text] [Related]
8. Lack of neuropeptide Y attenuates the somatic signs of opiate withdrawal.
Olson VG; Griner NB; Heusner CL; Palmiter RD
Synapse; 2006 Dec; 60(7):553-6. PubMed ID: 16952158
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR).
Navarro-Zaragoza J; Laorden ML; Milanés MV
Toxicology; 2014 Dec; 326():36-43. PubMed ID: 25308750
[TBL] [Abstract][Full Text] [Related]
10. The corticotropin-releasing factor receptor-2 mediates the motivational effect of opiate withdrawal.
Rouibi K; Contarino A
Neuropharmacology; 2013 Oct; 73():41-7. PubMed ID: 23707482
[TBL] [Abstract][Full Text] [Related]
11. Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: role of corticotropin-releasing factor (CRF) 1 receptor.
Navarro-Zaragoza J; Martínez-Laorden E; Mora L; Hidalgo J; Milanés MV; Laorden ML
Toxicol Appl Pharmacol; 2014 Feb; 275(1):28-35. PubMed ID: 24398105
[TBL] [Abstract][Full Text] [Related]
12. The CRF1 and the CRF2 receptor mediate recognition memory deficits and vulnerability induced by opiate withdrawal.
Morisot N; Contarino A
Neuropharmacology; 2016 Jun; 105():500-507. PubMed ID: 26907806
[TBL] [Abstract][Full Text] [Related]
13. The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal.
Skelton KH; Oren D; Gutman DA; Easterling K; Holtzman SG; Nemeroff CB; Owens MJ
Eur J Pharmacol; 2007 Sep; 571(1):17-24. PubMed ID: 17610870
[TBL] [Abstract][Full Text] [Related]
14. Selective down-regulation of hippocampal glucocorticoid receptors during opiate withdrawal.
McNally GP; Akil H
Brain Res Mol Brain Res; 2003 Oct; 118(1-2):152-5. PubMed ID: 14559365
[TBL] [Abstract][Full Text] [Related]
15. Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice.
Papaleo F; Contarino A
Behav Brain Res; 2006 Jun; 170(1):110-8. PubMed ID: 16580078
[TBL] [Abstract][Full Text] [Related]
16. Opiate exposure and withdrawal dynamically regulate mRNA expression in the serotonergic dorsal raphe nucleus.
Lunden JW; Kirby LG
Neuroscience; 2013 Dec; 254():160-72. PubMed ID: 24055683
[TBL] [Abstract][Full Text] [Related]
17. Conditioned aversive memory associated with morphine withdrawal increases brain-derived neurotrophic factor in dentate gyrus and basolateral amygdala.
Martínez-Laorden E; Navarro-Zaragoza J; Milanés MV; Laorden ML; Almela P
Addict Biol; 2020 Jul; 25(4):e12792. PubMed ID: 31282111
[TBL] [Abstract][Full Text] [Related]
18. Naloxone-induced conditioned place aversion score and extinction period are higher in C57BL/6J morphine-dependent mice than in Swiss: Role of HPA axis.
Navarro-Zaragoza J; Martínez-Laorden E; Teruel-Fernández FJ; Gómez-Murcia V; Cánovas A; Milanés MV; Laorden ML; Almela P
Pharmacol Biochem Behav; 2021 Feb; 201():173106. PubMed ID: 33444599
[TBL] [Abstract][Full Text] [Related]
19. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal.
Iredale PA; Alvaro JD; Lee Y; Terwilliger R; Chen YL; Duman RS
J Neurochem; 2000 Jan; 74(1):199-208. PubMed ID: 10617121
[TBL] [Abstract][Full Text] [Related]
20. CRF2 Receptor Deficiency Eliminates the Long-Lasting Vulnerability of Motivational States Induced by Opiate Withdrawal.
Morisot N; Rouibi K; Contarino A
Neuropsychopharmacology; 2015 Jul; 40(8):1990-2000. PubMed ID: 25672976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
